Male Breast Cancer Active Not Recruiting Phase 1 / 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00791037Vaccine Therapy in Treating Patients With Stage IV Breast CancerTreatment